Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target

Author:

Al-Hasan Majdi N12

Affiliation:

1. Department of Internal Medicine, University of South Carolina School of Medicine, Columbia, South Carolina, USA

2. Prisma Health-Midlands, Columbia, South Carolina, USA

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference14 articles.

1. Stratification of the impact of inappropriate empirical antimicrobial therapy for gram-negative bloodstream infections by predicted prognosis;Cain;Antimicrob Agents Chemother,2015

2. Empirical fluoroquinolones versus broad-spectrum beta-lactams for gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors;Al-Hasan;J Glob Antimicrob Resist,2019

3. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections;Al-Hasan;Clin Microbiol Infect,2020

4. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a non-inferiority randomized controlled trial;Yahav;Clin Infect Dis,2019

5. Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents;Kadri;Clin Infect Dis,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3